Did Statins Really Reduce the Risk of Cirrhosis and Decompensation in Chronic Hepatitis B Patients?

被引：0
|
作者：
Lo, Gin-Ho [1 ]
机构：
[1] I Shou Univ, Sch Med Int Students, Digest Ctr, E DA Hosp,Dept Med Res, 1 Yi Da Rd, Kaohsiung 824, Taiwan
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2017年 / 112卷 / 02期
关键词：
D O I：
10.1038/ajg.2016.486
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：386 / 387
页数：2
相关论文
共 50 条
  • [41] Does antiplatelet therapy really reduce the risk of hepatocellular carcinoma in hepatitis B patients with antiviral drugs?
    Lo, Gin-Ho
    HEPATOLOGY, 2018, 67 (04) : 1642 - 1643
  • [42] Increased Risk of Cirrhosis and Its Decompensation in Chronic Hepatitis C Patients With New-Onset Diabetes: A Nationwide Cohort Study
    Huang, Yi-Wen
    Yang, Sien-Sing
    Fu, Szu-Chieh
    Wang, Ting-Chuan
    Hsu, Cheng-Kai
    Chen, Ding-Shinn
    Hu, Jui-Ting
    Kao, Jia-Horng
    HEPATOLOGY, 2014, 60 (03) : 807 - 814
  • [43] Nomogram for cirrhosis in patients with chronic hepatitis B: A simple self-assessed scale for individual risk of cirrhosis
    Zhiqiao Zhang
    Jing Li
    Peng Wang
    Tingshan He
    Yanling Ouyang
    Yiyan Huang
    Scientific Reports, 7
  • [44] Nomogram for cirrhosis in patients with chronic hepatitis B: A simple self-assessed scale for individual risk of cirrhosis
    Zhang, Zhiqiao
    Li, Jing
    Wang, Peng
    He, Tingshan
    Ouyang, Yanling
    Huang, Yiyan
    SCIENTIFIC REPORTS, 2017, 7
  • [45] Association Between Nonselective Beta-Blocker Use and Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Without Cirrhosis and Decompensation
    Cheng, He-Yun
    Lin, Hsiu C. C.
    Lin, Hsiu L. L.
    Uang, Yow S. S.
    Keller, Joseph J. J.
    Wang, Li H. H.
    FRONTIERS IN PHARMACOLOGY, 2022, 12
  • [46] Risk of hepatocellular carcinoma and cirrhosis decompensation in a large retrospective cohort of cirrhotic patients with autoimmune hepatitis
    Mifleh Tatour
    Eli Zuckerman
    Naim Abu-Freha
    Rawi Hazzan
    Scientific Reports, 15 (1)
  • [47] ENTECAVIR VERSUS LAMIVUDINE IN THE TREATMENT OF CHRONIC HEPATITIS B PATIENTS WITH HEPATIC DECOMPENSATION
    Hsu, Yao-Chun
    Mo, Lein-Ray
    Chang, Chi-Yang
    Tseng, Cheng-Hao
    Lin, Jaw-Town
    HEPATOLOGY, 2011, 54 : 1009A - 1010A
  • [48] Hepatic Decompensation in Cirrhotic Patients Receiving Antiviral Therapy for Chronic Hepatitis B
    Lee, Hye Won
    Yip, Terry Cheuk-Fung
    Tse, Yee-Kit
    Wong, Grace Lai-Hung
    Kim, Beom Kyung
    Kim, Seung Up
    Park, Jun Yong
    Kim, Do Young
    Chan, Henry Lik-Yuen
    Ahn, Sang Hoon
    Wong, Vincent Wai-Sun
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 19 (09) : 1950 - +
  • [49] Fibrotest® (FT) and Actitest® (AT) accurately predict risk of liver decompensation and death in patients with chronic hepatitis B (CHB)
    Ngo, Yen
    Benhamou, Yves
    Munteanu, Mona
    Thibault, Vincent
    Lebray, Pascal
    Thabut, Dominique
    Morra, Rachel
    Messous, Djamila
    Imbert-Bismut, Francoise
    Ratziu, Vlad
    Poynard, Thierry
    HEPATOLOGY, 2007, 46 (04) : 637A - 637A
  • [50] Bacterial infection adversely increases the risk of decompensation in patients with hepatitis B virus-related compensated cirrhosis: a retrospective study
    Li, Yinglun
    Niu, Bin
    Liu, Jing
    Zhou, Hui
    Chen, Ze
    Zhou, Yibing
    Wei, Qian
    Jiao, Xue
    Mi, Yuqiang
    Li, Ping
    BMC INFECTIOUS DISEASES, 2024, 24 (01)
12345